KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Down 12.6% in December

KORU Medical Systems, Inc. (NASDAQ:KRMD) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 372,600 shares, a decline of 12.6% from the December 15th total of 426,400 shares. Currently, 0.9% of the shares of the company are short sold. Based on an average daily volume of 67,100 shares, the days-to-cover ratio is currently 5.6 days.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on KRMD shares. Piper Sandler increased their target price on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research note on Thursday, November 14th. Canaccord Genuity Group increased their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Lake Street Capital boosted their target price on KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a report on Tuesday, January 14th. Finally, Craig Hallum increased their price target on KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $4.50.

KORU Medical Systems Price Performance

Shares of KRMD stock opened at $4.09 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $4.60. The stock has a 50 day simple moving average of $3.82 and a 200-day simple moving average of $2.97.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. XTX Topco Ltd acquired a new position in shares of KORU Medical Systems during the 3rd quarter worth $34,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of KORU Medical Systems in the second quarter valued at about $107,000. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in KORU Medical Systems by 77.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after buying an additional 26,860 shares in the last quarter. Empire Financial Management Company LLC acquired a new position in KORU Medical Systems during the third quarter worth about $259,000. Finally, Geode Capital Management LLC increased its holdings in KORU Medical Systems by 6.5% in the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after buying an additional 28,323 shares in the last quarter. Hedge funds and other institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.